1. Home
  2. HCAT vs MXCT Comparison

HCAT vs MXCT Comparison

Compare HCAT & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • MXCT
  • Stock Information
  • Founded
  • HCAT 2008
  • MXCT 1999
  • Country
  • HCAT United States
  • MXCT United States
  • Employees
  • HCAT N/A
  • MXCT N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • HCAT Technology
  • MXCT Health Care
  • Exchange
  • HCAT Nasdaq
  • MXCT Nasdaq
  • Market Cap
  • HCAT 259.8M
  • MXCT 239.2M
  • IPO Year
  • HCAT 2019
  • MXCT 2021
  • Fundamental
  • Price
  • HCAT $4.10
  • MXCT $2.20
  • Analyst Decision
  • HCAT Buy
  • MXCT Strong Buy
  • Analyst Count
  • HCAT 11
  • MXCT 1
  • Target Price
  • HCAT $8.00
  • MXCT $9.00
  • AVG Volume (30 Days)
  • HCAT 672.5K
  • MXCT 874.5K
  • Earning Date
  • HCAT 08-06-2025
  • MXCT 08-05-2025
  • Dividend Yield
  • HCAT N/A
  • MXCT N/A
  • EPS Growth
  • HCAT N/A
  • MXCT N/A
  • EPS
  • HCAT N/A
  • MXCT N/A
  • Revenue
  • HCAT $311,274,000.00
  • MXCT $37,675,000.00
  • Revenue This Year
  • HCAT $11.23
  • MXCT $8.82
  • Revenue Next Year
  • HCAT $9.71
  • MXCT $21.12
  • P/E Ratio
  • HCAT N/A
  • MXCT N/A
  • Revenue Growth
  • HCAT 4.88
  • MXCT N/A
  • 52 Week Low
  • HCAT $3.49
  • MXCT $2.00
  • 52 Week High
  • HCAT $9.24
  • MXCT $5.20
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 48.15
  • MXCT 44.18
  • Support Level
  • HCAT $3.65
  • MXCT $2.00
  • Resistance Level
  • HCAT $3.93
  • MXCT $2.32
  • Average True Range (ATR)
  • HCAT 0.22
  • MXCT 0.11
  • MACD
  • HCAT 0.00
  • MXCT 0.01
  • Stochastic Oscillator
  • HCAT 40.91
  • MXCT 43.66

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: